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Guide to Therapeutic Oncology. Eds
D. R. BERGEVIN, J. BLOM & D. C. TORMEY
(1979) Baltimore: Williams & Wilkins.
668 pp. $55.00.
This "Guide to Therapeutic Oncology" is
one of a number of oncology text books pub-
lished recently. It is intended to be a concise
reference of the natural history, diagnostic
evaluation, and treatment of tumours. The
first section deals with the general principles
of treatment of cancer with surgery, radio-
therapy and chemotherapy. This is followed
by a section devoted to a review of cancer
chemotherapeutic agents. The 3rd and major
section of the book deals with the manage-
ment of various tumour groups.
Although entitled "Guide to Therapeutic
Oncology" the emphasis is strongly on cancer
chemotherapy, with little detail of surgery
or radiotherapy. Surgeons will not be pleased
to hear that their role is one of a primary
physician, and as a "technician" on the
physicians' team! The qualityof the contribu-
tions vary as in any multi-author book, but
the standard is generally high.
The text is well referenced, with a prefer-
ence as one would expect, for the American
literature. Oncology is such a fast-moving
subject that this text book like all its com-
petitors is out-of-date by the time it is
published. This book can, however, be recom-
mended as a chemotherapeutic guide to
cancer therapy with some background to
surgical and radiotherapeutic techniques.
J. H. SCARFFE
Radiation Oncology-Rationale, Tech-
nique, Results. Eds W. T. Moss, W. N.
BRAND & H. BATTIFORA (1979) St Louis:
C. V. Mosby. 648 pp. Price not given.
"Moss" has been an old friend for most
radiotherapists over the years since it was
first published in 1959 and the reviewer still
remembers with pleasure his discovery of the
book when a rather confused novice to the
subject. The book, with 2 additional authors,
is now in its 5th edition; a testimony to its
value and the demand for its continued
updating.
The book is not a comprehensive primer on
radiation therapy, and it is not suitable for
those who demand a didactic presentation
of how to treat an individual patient. It is,
however, an excellent integrated approach to
the philosophies of management. Its great
strength is its emphasis on the interaction of
radiation therapy to the tumour with that on
the host and his normal tissues. It is this
balance between tumour and normal-tissue
response in the patient which so frequently
determines the outcome of treatment.
Unlike many modern books, this one
remains unashamedly devoted to radio-
therapy, with little discussion of other
aspects of cancer treatment such as chemo-
therapy. It does, however, mention briefly
the current role of combined treatments,
wherever these are appropriate. It is not
therefore a book which should be regarded as
a detailed reference book. It is much more a
first class introduction to the subject, which
still presents its reader with unexpected gems
on re-reading and sources for further study.
It is always possible to criticise small points
in any book. Perhaps one might make a
general comment that the reviewer continues
to find it somewhat irritating that the empha-
sis is largely on North American radio-
therapy. In particular, the continued use of
the American Joint Committee for Cancer
Staging Classification instead of the Inter-
national U.I.C.C. system seems unnecessary.
The authors acknowledge that their views
have been selective and to some degree shaped
by their prejudices. It is therefore churlish
to be too critical about the selection of data
and techniques.
This is an excellent book which should be
on all radiotherapists' bookshelves.
N. M. BLEEHEN
Bladder Tumors and Other Topics in
Urological Oncology. Eds M. PAVONE-
MACALUSO, P. H. SMITH & F. EDSMYR
(1980) New York: Plenum Publishing Co.
528 pp. $59.50.
From the point of view of the surgeons,
radiotherapists, oncologists and experimental
pathologists involved in treatment of uro-BOOK REVIEWS 803
logical cancer, the meeting of which this
book is the proceedings acted as an important
focal point for the appraisal of current treat-
ment and research, and provided a forum to
discuss new directions for the future. Because
of the large number of papers on various
bladder-cancer topics (28 chapters on aspects
of staging and experimental pathology, 17
on surgical treatment, 9 on radiotherapy, 23
on chemotherapy) most of the chapters are
short data presentations, mostly new or an
update ofpreviously published work. Bladder
cancer is a disease which is predominantly
managed by surgeons. The chapters on the
variety of surgical approaches possible are
well presented, but the format ofthe chapters
gives little chance for an overall appraisal
of the relative merits of different approaches.
Perhaps the most fundamental question
raised was the relevance oflymph-node clear-
ance at cystectomy. Although manyEuropean
and American surgeons prefer the radical
technique because it simplifies the access to
remove the bladder, there is no data to
demonstrate its superiority over simple
cystectomy. The data reported from two
Dutch groups in fact demonstrates that, as in
carcinoma of the breast, the results from the
simple operation are as good and suggest that
there are less post-operative complications.
The papers on radiotherapy were not as
extensive as on surgical aspects, but there are
good contributions on the relative merits
and pelvic complications from use of 6 MeV
linear accelerator and Cobalt-60 therapy,
demonstrating the normal-tissue-sparing
effect from the former.
Chemotherapy for treatment of advanced
bladder cancer is not new, but only recently
has it become clear that this disease is as
chemoresponsive to single-agent therapy as
breast and head and neck tumours, justifying
trials of adjuvant therapy. Two pilot studies
with encouraging results are reported, but it
will be several years before data is available
from controlled trials.
Intravesical topical chemotherapy ofsuper-
ficial tumours has a long history, and although
new information demonstrating activity of
adriamycin and cis-platinum is presented, all
agents tested to date have about the same
level of activity. The lack of advantage of
these new drugs over the cheaper, long-
e3tablished agents Thiotepa and Epodyl,
makes it unlikely that they will be first-line
treatment.
Compared to the extensive data on bladder
cancer in this book, there were only a few
papers on cancer of the prostate (10, 4 of
which dealt with aspects of hormone recep-
tors) and 2 papers on testicular tumours. The
most important of these papers is an update
ofinformation from the Veterans Administra-
tive Prostatic Cancer trials, which have
caused considerable controversy in the U.S.A.
by suggesting that there is no place for radical
surgeryorearlyadjuvantendocrine manipula-
tion in this disease.
Although this book will probably be of
greatest value to surgeons in training or
involved in clinical research in urological
tumours, the fund of information and refer-
ences will be of considerable interest to
radiotherapists and oncologists needing an
introduction to the treatment of urological
cancer.
R. J. D. OLIVER
Fast Neutrons in the Treatment of
Cancer. M. CATTERALL & D. K. BEWLEY
(1979) London: Academic Press. 394 pp.
£22.40.
The cyclotron at the MRC Cyclotron Unit
at Hammersmith Hospital in London has
now been in use for 25 years, as a source of
radioisotopes for research and clinical use,
as a research tool for radiobiologists and as a
neutron source for radiotherapy. This book
gives an account ofthe pioneering work ofthe
Hammersmith team indevelopingthephysical
and biological background for neutron ther-
apy, and the subsequent 10 years of clinical
experience and clinical trials.
The first 3 chapters, on the discovery of
the neutron and the development of the
medical cyclotron, the production of neutron
beams, and the interaction of neutrons with
matter; dosimetry; depth-dose, give a wide-
ranging review of these basic topics with
adequate references to the now extensive
literature. Chapter 4, on radiobiological
aspects of neutron therapy, gives an account
of the basic radiobiology of fast neutrons,
and develops the biological arguments which
justify clinical experiments on the use of
fast neutrons for the treatment of cancer.
Quite properly, the emphasis in these chapters
is ontheworkdoneatHammersmithHospital,
as this has provided the basic data on which